Myelin basic protein administration in multiple sclerosis.
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003888:Desensitization, Immunologic; D005069:Evaluation Studies as Topic; D005260:Female; D005620:Freund's Adjuvant; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000276:immunology / Q000628:therapy*; D004676:Myelin Basic Protein; D009186:Myelin Sheath / Q000276:immunology; D009419:Nerve Tissue Proteins / Q000627:therapeutic use*; D010919:Placebos
D004676:Myelin Basic Protein; D009419:Nerve Tissue Proteins; D010919:Placebos; D005620:Freund's Adjuvant